XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.25.3

Restructuring, Strategic Transaction and Integration (Notes) | 9 Months Ended
--- | ---
Sep. 30, 2025
Restructuring and Related Activities [Abstract] |
Restructuring and Related Activities Disclosure | Restructuring, Strategic Transaction and Integration Restructuring, strategic transaction and integration expenses were $13.1 million and $46.1 million for the three and nine months ended September 30, 2025, respectively, as compared to $16.8 million and $50.1 million for the three and nine months ended September 30, 2024, respectively. Restructuring During the three and nine months ended September 30, 2025 restructuring charges were $6.2 million and $21.2 million, respectively, as compared to $3.6 million and $16.6 million for the three and nine months ended September 30, 2024, respectively, and were primarily related to facility closure costs and severance costs. The following table summarizes the activity in our restructuring-related accrual by major type of cost for the three and nine months ended September 30, 2025 (in thousands), which is included in accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets:
|  | Employee & Related Costs |  |  |  | Facility & Other Closure Costs |  | Total
Accrued balance, January 1, 2025 |  | $ | 9,538 |  |  |  |  | $ | 407 |  |  | $ | 9,945 |
Charges incurred |  | 2,401 |  |  |  |  | 4,397 |  |  | 6,798 |
Payments |  | (3,482) |  |  |  |  | (2,905) |  |  | (6,387) |
Other(1) |  | (900) |  |  |  |  | — |  |  | (900) |
Currency translation |  | 155 |  |  |  |  | 14 |  |  | 169 |
Accrued balance, March 31, 2025 |  | $ | 7,712 |  |  |  |  | $ | 1,913 |  |  | $ | 9,625 |
Charges incurred |  | 4,289 |  |  |  |  | 3,934 |  |  | 8,223 |
Payments |  | (3,930) |  |  |  |  | (2,538) |  |  | (6,468) |
Currency translation |  | 287 |  |  |  |  | 95 |  |  | 382 |
Accrued balance, June 30, 2025 |  | $ | 8,358 |  |  |  |  | $ | 3,404 |  |  | $ | 11,762 |
Charges incurred |  | 2,901 |  |  |  |  | 3,267 |  |  | 6,168 |
Payments |  | (3,409) |  |  |  |  | (3,389) |  |  | (6,798) |
Currency translation |  | 41 |  |  |  |  | (26) |  |  | 15 |
Accrued balance, September 30, 2025 |  | $ | 7,891 |  |  |  |  | $ | 3,256 |  |  | $ | 11,147 |
__________________________ (1) Relates to prior year accrued restructuring charges for estimated severances costs that were reclassed to other accounts during the three months ended March 31, 2025. Strategic Transaction and Integration Expenses We incurred and expensed $6.9 million and $24.9 million in strategic transaction and integration expenses during the three and nine months ended September 30, 2025, respectively, as compared to $13.2 million and $33.5 million in strategic transaction and integration expenses during the three and nine months ended September 30, 2024, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three and nine months ended September 30, 2025 and 2024 were primarily related to ongoing consulting expenses and employee costs incurred to integrate our Smiths Medical business acquired in 2022. The nine months ended September 30, 2025 also included transaction costs related to the sale of a 60% ownership in our IV Solutions business in the second quarter of 2025.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/420/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration